Investigation | 1 month before admission | This admission | 6 months after admission | Reference range |
---|---|---|---|---|
Plasma glucose, mg/dl | 87 | 794 | 210 | 70–99 |
HbA1C, % | N/A | 6.5 | 7.0 | 4.0–5.6 |
Beta-hydroxybutyrate, mmol/L | N/A | 6.3 | N/A | 0–0.6 |
Sodium, mmol/L | 135 | 119 | 140 | 136–145 |
Potassium, mmol/L | 3.3 | 6.5 | 3.4 | 3.4–4.5 |
Chloride, mmol/L | 97 | 82 | 99 | 95–105 |
Bicarbonate, mmol/L | 28 | 13 | 26 | 22–29 |
Anion gap, mmol/L | 10 | 24 | 15 | 8–16 |
Blood urea nitrogen, mg/dl | 5 | 39 | N/A | 7–20 |
Creatinine, mg/dl | 0.75 | 1.8 | 0.82 | 0.7–1.2 |
Amylase, U/L | N/A | 60 | N/A | 20–100 |
Lipase, U/L | N/A | 53 | N/A | 10–60 |
Anti-GAD, IU/ml | N/A | 3.09 | N/A | < 17 |
Anti-IA2, IU/ml | N/A | < 7.5 | N/A | < 7.5 |
C-peptide | N/A | < 0.1 | N/A | 0.9–7.1 |
8:00 a.m. cortisol, ng/ml | N/A | 0.6 | N/A | 3–18 |
ACTH, pg/ml | N/A | 21.7 | N/A | 0–46 |
FT4, ng/dl | N/A | 1.22 | 1.19 | 0.8–1.8 |
TSH, μIU/ml | N/A | 2.94 | 2.560 | 0.3–4.1 |
FSH, IU/L | N/A | 17.7 | 13.9 | 1–8.4 |
LH, IU/L | N/A | 19.4 | 8.1 | 1–10.5 |
Testosterone, nmol/L | N/A | 24.46 | 14.89 | 5.9–24.7 |
IGF-1, ng/ml | N/A | N/A | 66.4 | 24.6–269 |
Prolactin, ng/ml | N/A | 15.9 | 6.7 | 2–25 |